[Staphylococcus aureus sepsis in patients with hematological malignancies: increase in MRSA sepsis]

Rinsho Ketsueki. 1991 Feb;32(2):115-20.
[Article in Japanese]

Abstract

From January 1978 to August 1990, Staphylococcus aureus bacteremia (SAB) were identified in 31 patients with hematological malignancies at Jichi Medical School hospital. Mortality due to SAB was 48.4% (15/31). Of the variables analyzed, four factors were significantly associated with a poor prognosis; elderly age (p = 0.015), high granulocyte count (more than 500/microliters) (p = 0.015), presence of DIC (p = 0.011) and presence of pneumonia (p = 0.023). The incidence of methicillin-resistant SAB was 32.3% (10/31) and the first patient developed in 1985. Although not statistically significant, there was a trend of higher mortality for methicillin-resistant SAB (70%) than for methicillin-sensitive SAB (38.1%). Most strains of methicillin-resistant Staphylococcus aureus were sensitive to minocycline, chloramphenicol and vancomycin.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chloramphenicol / pharmacology
  • Female
  • Humans
  • Leukemia / complications*
  • Male
  • Methicillin Resistance
  • Middle Aged
  • Minocycline / pharmacology
  • Prognosis
  • Sepsis / etiology*
  • Sepsis / microbiology
  • Staphylococcal Infections / etiology*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Vancomycin / pharmacology

Substances

  • Chloramphenicol
  • Vancomycin
  • Minocycline